Get started
Author

Serpil Taşdelen

Observed names: S. TASDELEN, S.TASDELEN, Serpil TAŞDELEN, Serpil Tasdelen, TASDELEN, Serpil, Tasdelen, Serpil
ORCID: 0000-0003-2241-6907
Observed ORCID: 0000-0003-2241-6907
OpenAlex ID: A5090296316
Coffee-Derived Exosome-Like Nanoparticles: Are They the Secret Heroes?
2022 · Murat Kantarcıoğlu, Gülşen Yıldırım, et al. · The Turkish Journal of Gastroenterology · 51
Factor V Leiden and Prothrombin 20210A Mutations among Turkish Pediatric Leukemia Patients
2012 · Dilara Fatma Akın, Kadir Sipahi, et al. · Leukemia Research and Treatment · 6
PDF
Genetic Profiling of Pediatric Patients with B-Cell Precursor Acute Lymphoblastic Leukemia
2022 · Dilara Fatma Akin-Bali, Beyza Doganay Erdogan, et al. · Journal of Pediatric Genetics · 2
PDF
C0369 Factor V leiden and prothrombin 20210A mutations among turkish pediatric leukemia patients
2012 · Dilara Fatma Akin, Kadir Sipahi, et al. · Thrombosis Research · 1
Evaluation of the Efficacy of Asparaginase Added to Chemotherapeutic Drug Regimen in Acute Lymphoblastic Leukemia by Minimal Residual Disease Measurement
2024 · Pınar Akpınar Oktar, Merve Güneş, et al. · Hacettepe Journal of Biology and Chemistry
PDF
Upstream Process Protocol for MSCs Isolated from Different Human-Based Tissue Origins
2024 · Pelin Kılıç, Cansu Özdemir, et al. · Methods in molecular biology
How Much Resistance is Considered During Prophylaxis Recommendation? A Case Report of Infective Endocarditis with Multi-Drug Resistant Streptococcus Despite Appropriate Prophylaxis Before Dental Intervention
2020 · Emel BAYRAK, Müberra Devrim GÜNER, et al. · Turkiye Klinikleri Journal of Case Reports
PDF
Works count: 14
Citation count: 60
H-index: 2
I10-index: 1
Year
Topic
Type